Displaying 1141 - 1170 of 17006
-
-
Fading Eyesight Helps UCSF’s Angela Woon Find ‘Saving Grace’
Angela Woon, an IT Communications Analyst at UCSF, avid runner, and writer, shares her story and experience with Retinitis Pigmentosa (RP), a condition that will eventually cause her sight to fully deteriorate.
-
The Growing Case for Doing Less: How Harmless Cancers Are Being Overdiagnosed in America
-
She Got off Dialysis. Her Doctor Thinks Others With Acute Kidney Injury Can Too
-
Brief Dialysis May Be Best for Some Kidney Patients
Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.
-
Can a Simple Fentanyl Test Curb San Francisco’s Overdose Crisis?
With fentanyl overdose deaths at an all-time high, a successful UCSF-funded pilot project to distribute fentanyl test strips is being expanded by California Gov. Gavin Newsome as part of his plan to address the crisis.
-
An AirPod-Sized Wearable That Can Relieve Kids’ Gut Pain
A small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).
-
UCSF Research Vital to First Drug for Deadly Bone Disease
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
-
Will a Pill Help New Moms Bounce Back from Postpartum Depression?
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
-
How a Unique Summer Camp Connects Kids With Limb Differences
Camp Winning Hands is a free summer camp for kids and teens with limb differences, where campers enjoy all types of activities that are modified for their unique conditions.
-
UCSF Rallies on Capitol Hill as Cuts to ‘Essential’ NIH Funds Debated
UCSF students and postdocs join advocates from around the country for the 2023 Rally for Medical Research to call on our nation’s policymakers to make funding for NIH a national priority and raise awareness about the importance of continued investment in medical research.
-
UCSF Is Trying a New Tactic to Eradicate Long COVID Symptoms. Here’s How It Works
-
Vizient Awards UCSF Health Top Marks for Quality Patient Care
Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.
-
‘Wormnado’ Wiggles its Way to Win at Postdoc Slam
Laura Persson, PhD, wins the 2023 Postdoc Slam with her talk titled “The Wormnado: What a tiny worm can teach us about collective behavior.”
-
Shared Mechanisms Allow SARS-CoV-2 Variants to Thrive Post-Vaccination
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
-
UCSF Gains Approval for New Research Building at Parnassus Heights
UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.
-
New COVID-19 Vaccines: Is it Worth the Shot?
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
-
150 Milestone: Robotic Procedure Changes Prostate Cancer Care
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.
-
From AI to Cancer, Arc Institute Supports Curiosity-Driven Science at UCSF
Discoveries result from a mix of smarts, creativity, grit, collaboration, serendipity and time. But when scientists must constantly apply for funding, that last factor can be hard to come by. The Arc
-
MDMA’s Latest Trial Results Offer Hope for Patients with PTSD
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
-
How Does Smoking Tobacco and Cannabis Affect Depression Risk?
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.
-
Sleep-Wake Therapy Gives New Hope for Teens with Depression
A new intervention may help “night owl” kids adjust to their natural sleep-cycle rhythms, fulfill their school responsibilities and avoid depression.
-
Telecare Cuts Costs, Boosts Quality of Life for Dementia Patients
A UCSF telecare program improves outcomes for patients with dementia and lightens the load for unpaid caregivers while cutting Medicare costs.
-
Study Finds Significant Chemical Exposures in Women With Cancer
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
-
Protect Yourself and Loved Ones with the New RSV Vaccines
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
-
Malnutrition Early in Life Sets Stage for Poor Growth and Death
Babies who experience malnutrition may also experience worse cognitive development and have higher chances of death.
-
Lancet Commission Calls for Renewed Global Response on TB
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
-
Pride Hall Opens, a Highlight of UCSF’s Partnership with the City
UCSF Pride Hall, UCSF’s new research and academic building at Zuckerberg San Francisco General Hospital and Trauma Center, will house more than 800 UCSF employees, including about 200 physician-scientists and clinicians.
-
‘When Your Child Can’t Breathe, It Is Scary’
A specialized asthma clinic at UCSF Benioff Children’s Hospital provides personalized asthma care and education for East Bay children and their families.
-
Are the Newest Weight Loss Drugs Too Good to be True?
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.
